Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2024-11-27 | Mr. Christopher joined Lexaria on August 31, 2024 to succeed Christopher Bunka as CEO... He was the Chief Financial Officer of Invivo Therapeutics Holdings Corp. and iCAD, Inc., both companies in the medical technology and biotechnology sectors. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-25